Clinical Trial

This Study is to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of HSK47388 in Healthy Volunteers

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated April 13, 2025 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a single-center, randomized, double-blind, placebo-controlled, SAD study to evaluate the safety, tolerability and PK of HSK47388 in healthy adult participants and preliminarily evaluate the PD of HSK47388
Trial Details
NCT Number NCT06926218
Lead Sponsor Haisco Pharmaceutical Group Co., Ltd.
Conditions Healthy
Enrollment 40 participants
Start Date 2025-05
Primary Completion 2025-07 (estimated)
Study Completion 2025-09 (estimated)
Updated on ClinicalTrials.gov 2025-04-13